Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2002
11/07/2002WO2001046408A9 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
11/07/2002WO2001040449A9 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof
11/07/2002US20020166133 Neokine protein and nucleic acid molecules and uses therefor
11/07/2002US20020166132 System for regulating in vivo the expression of a transgene by conditional inhibition
11/07/2002US20020165386 C-junction-n-terminal kinase (JNK); microbiocides; treating neurodegenerative diseases
11/07/2002US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002US20020165377 ADAM polynucleotides, polypeptides, and antibodies
11/07/2002US20020165375 Parasitic helminth cuticlin proteins and uses thereof
11/07/2002US20020165373 Contacting the sample with an isolated recombinant immunodominant Neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex
11/07/2002US20020165371 Compositions and methods for the therapy and diagnosis of breast cancer
11/07/2002US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002US20020165355 Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
11/07/2002US20020165193 Compositions and methods of treating tumors
11/07/2002US20020165183 Methods for genetic immunization
11/07/2002US20020165172 Compositions and methods for treating intracellular diseases
11/07/2002US20020165156 Tumor necrosis factor family and its blocking agent
11/07/2002US20020165154 Lipoprotein-regulating medicaments
11/07/2002US20020165138 Compositions and methods for the treatment of sepsis
11/07/2002US20020165131 Histidine-rich glycoprotein
11/07/2002US20020165128 Compositions and methods for proteolytically inactivating infectious agents using lactoferrin and related molecules
11/07/2002US20020164789 Suppressing glial cell activation in central nervous system; obtain mammal with brain disorder, administer modulator of nervous system activity, evaluate for adjusstment in brain disorder
11/07/2002US20020164786 Novel telomerase
11/07/2002US20020164770 DNA transfection system for the generation of infectious influenza virus
11/07/2002US20020164760 Catalytically active recombinant memapsin and methods of use thereof
11/07/2002US20020164759 Dipeptidylpeptidase for use inthe treatment and prevention of periodonital disease
11/07/2002US20020164734 Human pelota homolog
11/07/2002US20020164721 Design of a polyepitopic construct for the induction of HLA-A2.1 restricted HIV 1 specific CTL responses using HHD mice
11/07/2002US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002US20020164714 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders
11/07/2002US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002US20020164704 Novel human monocyte chemotactic proprotein
11/07/2002US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
11/07/2002US20020164697 Nucleotide sequences coding polypeptides for use in treatment of autoimmune disease
11/07/2002US20020164679 Polypeptides for use in the treatment of atherosclerosis and cardiovascular disorders
11/07/2002US20020164668 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
11/07/2002US20020164665 Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof
11/07/2002US20020164615 Protein complex for use in the dianosis and treatment of nervous system disorders, alzheimer's and non-insulin dependent diabetes mellitus
11/07/2002US20020164603 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses
11/07/2002US20020164600 PD-L2 molecules: novel PD-1 ligands and uses therefor
11/07/2002US20020164582 Nucleotide sequences coding protein for use in the treatment of viral diseases
11/07/2002US20020164387 Herbal composition and method for controlling body weight and composition
11/07/2002US20020164372 Controlled release systems for polymers
11/07/2002US20020164359 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
11/07/2002US20020164358 Culturing human cancer cells; purification, recovering of antigens
11/07/2002US20020164357 Lipopolysaccharides from gramnegative bacteria
11/07/2002US20020164356 Attenuated recombinant rabies virus mutants and live vaccines thereof
11/07/2002US20020164355 Test to detect antibodies; calibration
11/07/2002US20020164353 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
11/07/2002US20020164350 Chimeric papillomavirus-like particles
11/07/2002US20020164349 Induction apoptosis; west nile virus therapy
11/07/2002US20020164347 Neoglycoproteins
11/07/2002US20020164346 Induce, moderate immunology response
11/07/2002US20020164345 Compositions and methods for the therapy and diagnosis of colon cancer
11/07/2002US20020164344 Anticancer agents; vaccines
11/07/2002US20020164343 Administering cold carbon dioxide; heating; precipitation
11/07/2002US20020164342 Recombinant cat allergen, Fel dI, expressed in baculovirus for diagnosis and treatment of cat allergy
11/07/2002US20020164341 Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
11/07/2002US20020164340 Multivalent MHC class II - peptide chimeras
11/07/2002US20020164338 Combined approach to treatment of cancer with hCG vaccines
11/07/2002US20020164337 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
11/07/2002US20020164336 Combination anti-selectin and immunosuppressant therapy
11/07/2002US20020164334 Antibody-induced apoptosis
11/07/2002US20020164331 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
11/07/2002US20020164326 Genetic engineering; administering immunoglobulins
11/07/2002US20020164321 Compositions and methods for treating retroviral infections
11/07/2002US20020164318 Cell lines and vectors for stimulation of an immune response to a differentiation antigen stimulated by an altered antigen
11/07/2002US20020164312 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/07/2002US20020164306 Concurrent administering with protein replacement therapy
11/07/2002US20020164287 Azo compounds for type i phototherapy
11/07/2002DE10120630A1 Pharmazeutische Zusammensetzung enthaltend Bulbophyllum A pharmaceutical composition comprising Bulbophyllum
11/07/2002DE10120505A1 Verwendung von stimulierten mononukleären Zellen des peripheren Blutes zur Behandlung von Krebserkrankungen Use of stimulated peripheral blood mononuclear cells for the treatment of cancer
11/07/2002CA2715570A1 Cripto blocking antibodies and uses thereof
11/07/2002CA2446408A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
11/07/2002CA2445978A1 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002CA2445974A1 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
11/07/2002CA2445887A1 Haemophilus influenzae antigens
11/07/2002CA2445826A1 Treatment and diagnosis of macrophage mediated disease
11/07/2002CA2445593A1 Genetically modified yt cell line and use thereof
11/07/2002CA2445382A1 Method for generating highly active human dendritic cells from monocytes
11/07/2002CA2445349A1 Anti-cd40 monoclonal antibody
11/07/2002CA2445310A1 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen
11/07/2002CA2445266A1 Foot and mouth disease virus vaccine
11/07/2002CA2445120A1 Devices for the intradermal administration of influenza vaccines
11/06/2002EP1254666A1 Stable antibody compositions and injection preparations
11/06/2002EP1254657A2 Liposomes
11/06/2002EP1254371A2 Selecting and producing t cell peptide epitopes
11/06/2002EP1254267A1 Compositions and methods for the early diagnosis of ovarian cancer
11/06/2002EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002EP1254256A2 Novel nucleic acids and polypeptides
11/06/2002EP1254242A1 17 human secreted proteins
11/06/2002EP1254240A2 Proteins producing an altered immunogenic response and methods of making and using the same
11/06/2002EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/06/2002EP1254233A1 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis
11/06/2002EP1254224A2 Interferon-alpha induced genes
11/06/2002EP1254220A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
11/06/2002EP1254213A2 Recombinant attenuation of prrsv
11/06/2002EP1254180A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody
11/06/2002EP1254176A2 Trade molecules and uses related thereto
11/06/2002EP1254168A2 Cytokine inhibittory molecules from tick salivary glands
11/06/2002EP1254156A1 Transgenic plant-based vaccines
1 ... 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 ... 1823